UK markets close in 8 hours 22 minutes

ADMA Biologics, Inc. (ADMA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.79-0.02 (-0.23%)
At close: 04:00PM EDT
8.70 -0.09 (-1.02%)
After hours: 07:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
283,176
258,215
154,080
80,943
42,220
Cost of revenue
171,639
169,273
118,815
79,770
61,291
Gross profit
111,537
88,942
35,265
1,173
-19,072
Operating expenses
Research development
2,895
3,300
3,614
3,646
5,907
Selling general and administrative
60,147
59,020
52,458
42,897
35,051
Total operating expenses
67,271
67,310
74,630
59,547
45,843
Operating income or loss
44,266
21,632
-39,365
-58,374
-64,915
Interest expense
22,681
25,027
19,279
13,057
11,985
Total other income/expenses net
-26,469
-26,461
-7,305
-252
863.269
Income before tax
-3,049
-28,239
-65,904
-71,648
-75,749
Income from continuing operations
-3,644
-28,239
-65,904
-71,648
-75,749
Net income
-3,644
-28,239
-65,904
-71,648
-75,749
Net income available to common shareholders
-3,644
-28,239
-65,904
-71,648
-75,749
Basic EPS
-0.11
-
-0.33
-0.51
-0.88
Diluted EPS
-0.11
-
-0.33
-0.51
-0.88
Basic average shares
218,201
-
197,875
139,579
86,145
Diluted average shares
218,201
-
197,875
139,579
86,145